Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer.
Department of Clinical Oncology, Rosemere Cancer Centre, Royal Preston Hospital, UK. Electronic address: davidthomson@doctors.org.uk.
David
D
Thomson
Department of Clinical Oncology, Rosemere Cancer Centre, Royal Preston Hospital, UK.
Natalie
N
Charnley
Department of Clinical Oncology, Rosemere Cancer Centre, Royal Preston Hospital, UK.
Omi
O
Parikh
D000737:Androstenols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
D000737:Androstenols; D043823:Taxoids; D010669:Phenylthiohydantoin